MTOR, linking metabolism and immunity

Seminars in Immunology

Volumn 24, Issue 6, 2012, Pages 429-435

  Xu, Xiaojin ^a   Ye, Lilin ^a   Araki, Koichi ^a   Ahmed, Rafi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; B cells; Metabolism; MTOR; Rapamycin; T cells

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

AUTOPHAGY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FATE; CELL METABOLISM; CELLULAR IMMUNITY; EFFECTOR CELL; HUMORAL IMMUNITY; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; MICROENVIRONMENT; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; VACCINATION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; IMMUNITY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES;

EID: 84874271196     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.12.005     Document Type: Review

References (75)

1. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
2. Dazert E., Hall M.N. mTOR signaling in disease. Current Opinion in Cell Biology 2011, 23:744-755.
3. Thomson A.W., Turnquist H.R., Raimondi G. Immunoregulatory functions of mTOR inhibition. Nature Reviews Immunology 2009, 9:324-337.
4. Laplante M., Sabatini D.M. mTOR signaling at a glance. Journal of Cell Science 2009, 122:3589-3594.
5. Mamane Y., Petroulakis E., LeBacquer O. Sonenberg N. mTOR, translation initiation and cancer. Oncogene 2006, 25:6416-6422.
6. Beugnet A., Tee A.R., Taylor P.M., Proud C.G. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochemical Journal 2003, 372:555-566.
7. Chen C., Liu Y., Liu R., Ikenoue T., Guan K.L., Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. Journal of Experimental Medicine 2008, 205:2397-2408.
8. Cybulski N., Hall M.N. TOR complex 2: a signaling pathway of its own. Trends in Biochemical Sciences 2009, 34:620-627.
9. Zinzalla V., Stracka D., Oppliger W., Hall M.N. Activation of mTORC2 by association with the ribosome. Cell 2011, 144:757-768.
10. Abraham R.T., Wiederrecht G.J. Immunopharmacology of rapamycin. Annual Review of Immunology 1996, 14:483-510.
11. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Molecular Cell 2006, 22:159-168.
12. Halloran P.F. Immunosuppressive drugs for kidney transplantation. New England Journal of Medicine 2004, 351:2715-2729.
13. Salmond R.J., Zamoyska R. The influence of mTOR on T helper cell differentiation and dendritic cell function. European Journal of Immunology 2011, 41:2137-2141.
14. Powell J.D., Delgoffe G.M. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 2010, 33:301-311.
15. Araki K., Ellebedy A.H., Ahmed R. TOR in the immune system. Current Opinion in Cell Biology 2011, 23:707-715.
16. Araki K., Youngblood B., Ahmed R. The role of mTOR in memory CD8 T-cell differentiation. Immunological Reviews 2010, 235:234-243.
17. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations (*). Annual Review of Immunology 2010, 28:445-489.
18. O'Shea J.J., Lahesmaa R., Vahedi G., Laurence A., Kanno Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nature Reviews Immunology 2011, 11:239-250.
19. O'Shea J.J., Paul W.E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010, 327:1098-1102.
20. Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nature Reviews Immunology 2012, 12:325-338.
21. Waickman A.T., Powell J.D. Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. Journal of Immunology 2012, 188:4721-4729.
22. Delgoffe G.M., Kole T.P., Zheng Y., Zarek P.E., Matthews K.L., Xiao B., et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009, 30:832-844.
23. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature Immunology 2011, 12:295-303.
24. Lee K., Gudapati P., Dragovic S., Spencer C., Joyce S., Killeen N., et al. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 2010, 32:743-753.
25. Powell J.D., Pollizzi K.N., Heikamp E.B., Horton M.R. Regulation of immune responses by mTOR. Annual Review of Immunology 2012, 30:39-68.
26. Crotty S. Follicular helper CD4 T cells (TFH). Annual Review of Immunology 2011, 29:621-663.
27. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory T cells: mechanisms of differentiation and function. Annual Review of Immunology 2012, 30:531-564.
28. Battaglia M., Stabilini A., Roncarolo M.G. Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells. Blood 2005, 105:4743-4748.
29. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. Journal of Experimental Medicine 2011, 208:1367-1376.
30. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. Journal of Immunology 2011, 186:3299-3303.
31. Sundrud M.S., Koralov S.B., Feuerer M., Calado D.P., Kozhaya A.E., Rhule-Smith A., et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science 2009, 324:1334-1338.
32. Waickman A.T., Powell J.D. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunological Reviews 2012, 249:43-58.
33. Sun Q., Chen X., Ma J., Peng H., Wang F., Zha X., et al. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:4129-4134.
34. Duvel K., Yecies J.L., Menon S., Raman P., Lipovsky A.I., Souza A.L., et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell 2010, 39:171-183.
35. Gabrysova L., Christensen J.R., Wu X., Kissenpfennig A., Malissen B., O'Garra A. Integrated T-cell receptor and costimulatory signals determine TGF-beta-dependent differentiation and maintenance of Foxp3+ regulatory T cells. European Journal of Immunology 2011, 41:1242-1248.
36. Pereira J.P., Kelly L.M., Cyster J.G. Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. International Immunology 2010, 22:413-419.
37. Victora G.D., Nussenzweig M.C. Germinal centers. Annual Review of Immunology 2012, 30:429-457.
38. MacLennan I.C. Germinal centers. Annual Review of Immunology 1994, 12:117-139.
39. Gourley T.S., Wherry E.J., Masopust D., Ahmed R. Generation and maintenance of immunological memory. Seminars in Immunology 2004, 16:323-333.
40. Donahue A.C., Fruman D.A. Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli. European Journal of Immunology 2007, 37:2923-2936.
41. Sakata A., Kuwahara K., Ohmura T., Inui S., Sakaguchi N. Involvement of a rapamycin-sensitive pathway in CD40-mediated activation of murine B cells in vitro. Immunology Letters 1999, 68:301-309.
42. Aagaard-Tillery K.M., Jelinek D.F. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cellular Immunology 1994, 156:493-507.
43. Kay J.E., Kromwel L., Doe S.E., Denyer M. Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology 1991, 72:544-549.
44. Wicker L.S., Boltz R.C., Matt V., Nichols E.A., Peterson L.B., Sigal N.H. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. European Journal of Immunology 1990, 20:2277-2283.
45. Zhang S., Readinger J.A., DuBois W., Janka-Junttila M., Robinson R., Pruitt M., et al. Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood 2011, 117:1228-1238.
46. Benhamron S., Tirosh B. Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells. European Journal of Immunology 2011, 41:2390-2396.
47. Plotkin S.A. Vaccines: Correlates of Vaccine-induced Immunity. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2008, vol. 47. pp. 401-409.
48. Pearce E.L., Walsh M.C., Cejas P.J., Harms G.M., Shen H., Wang L.S., et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009, 460:103-107.
49. Araki K., Turner A.P., Shaffer V.O., Gangappa S., Keller S.A., Bachmann M.F., et al. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108-112.
50. Rao R.R., Li Q., Odunsi K., Shrikant P.A. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 2010, 32:67-78.
51. Wherry E.J., Ahmed R. Memory CD8 T-cell differentiation during viral infection. Journal of Virology 2004, 78:5535-5545.
52. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nature Immunology 2003, 4:1191-1198.
53. He S., Kato K., Jiang J., Wahl D.R., Mineishi S., Fisher E.M., et al. Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells. PLoS One 2011, 6:e20107.
54. Wu T., Wieland A., Araki K., Davis C.W., Ye L., Hale J.S., et al. Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:9965-9970.
55. Wang Y., Wang X.Y., Subjeck J.R., Shrikant P.A., Kim H.L. Temsirolimus an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines. British Journal of Cancer 2011, 104:643-652.
56. Ferrer I.R., Wagener M.E., Robertson J.M., Turner A.P., Araki K., Ahmed R., et al. Cutting edge: rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. Journal of Immunology 2010, 185:2004-2008.
57. Turner A.P., Shaffer V.O., Araki K., Martens C., Turner P.L., Gangappa S., et al. Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. American Journal of Transplantation 2011, 11:613-618.
58. Colombetti S., Basso V., Mueller D.L., Mondino A. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. Journal of Immunology 2006, 176:2730-2738.
59. Kuo C.J., Chung J., Fiorentino D.F., Flanagan W.M., Blenis J., Crabtree G.R. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 1992, 358:70-73.
60. Stephenson L.M., Park D.S., Mora A.L., Goenka S., Boothby M. Sequence motifs in IL-4R alpha mediating cell-cycle progression of primary lymphocytes. Journal of Immunology 2005, 175:5178-5185.
61. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. Journal of Experimental Medicine 2009, 206:3015-3029.
62. Jones R.G., Thompson C.B. Revving the engine: signal transduction fuels T cell activation. Immunity 2007, 27:173-178.
63. Wang R., Dillon C.P., Shi L.Z., Milasta S., Carter R., Finkelstein D., et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2012, 35:871-882.
64. Frauwirth K.A., Riley J.L., Harris M.H., Parry R.V., Rathmell J.C., Plas D.R., et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002, 16:769-777.
65. Michalek R.D., Gerriets V.A., Nichols A.G., Inoue M., Kazmin D., Chang C.Y., et al. Estrogen-related receptor-alpha is a metabolic regulator of effector T-cell activation and differentiation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:18348-18353.
66. Buller C.L., Loberg R.D., Fan M.H., Zhu Q., Park J.L., Vesely E., et al. A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. American Journal of Physiology: Cell Physiology 2008, 295:C836-C843.
67. Gottesdiener K.M., Karpinski B.A., Lindsten T., Strominger J.L., Jones N.H., Thompson C.B., et al. Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation. Molecular and Cellular Biology 1988, 8:3809-3819.
68. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology 2011, 13:132-141.
69. Pua H.H., Guo J., Komatsu M., He Y.W. Autophagy is essential for mitochondrial clearance in mature T lymphocytes. Journal of Immunology 2009, 182:4046-4055.
70. Jia W., Pua H.H., Li Q.J., He Y.W. Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes. Journal of Immunology 2011, 186:1564-1574.
71. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
72. Pua H.H., Dzhagalov I., Chuck M., Mizushima N., He Y.W. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. Journal of Experimental Medicine 2007, 204:25-31.
73. Li C., Capan E., Zhao Y., Zhao J., Stolz D., Watkins S.C., et al. Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. Journal of Immunology 2006, 177:5163-5168.
74. Tamas P., Hawley S.A., Clarke R.G., Mustard K.J., Green K., Hardie D.G., et al. Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. Journal of Experimental Medicine 2006, 203:1665-1670.
75. Paul S., Kashyap A.K., Jia W., He Y.W., Schaefer B.C. Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-kappaB. Immunity 2012, 36:947-958.